4.0 Review

The Function of Heparanase in Diabetes and its Complications

期刊

CANADIAN JOURNAL OF DIABETES
卷 37, 期 5, 页码 332-338

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jcjd.2013.05.008

关键词

cardiomyopathy; diabetes; heparanase

资金

  1. Canadian Institutes of Health Research
  2. Canadian Diabetes Association
  3. Doctoral Student Research Award from the Canadian Diabetes Association

向作者/读者索取更多资源

Heparan sulfate proteoglycans are ubiquitous glycoproteins that contain several heparan sulfate polysaccharide side chains attached to a core protein. They function not only as a primary structural component of the extracellular matrix, but also provide a storage depot for bioactive molecules, such as basic fibroblast growth factor, vascular endothelial growth factor and lipoprotein lipase. Heparanase is an endoglycosidase that specifically hydrolyzes heparan sulfate into oligosaccharides. Recent studies have indicated that heparanase is engaged in the initiation and progression of diabetes, in addition to its associated complications. This review focuses on the participation of heparanase in the cleavage of heparan sulfate proteoglycans in pancreatic islets promoting beta cell death, promotion of atherosclerosis, and its role in cardiac metabolic switching in the early stage of cardiomyopathy during diabetes. Understanding the mechanisms by which heparanase is regulated in diabetes could provide a drug target to prevent diabetes and its complications. (C) 2013 Canadian Diabetes Association

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据